VAERS reports by lot

Merck HPV lot M040412: VAERS reports

64 VAERS reports list lot M040412 as a Merck HPV vaccine, received between 2017-03-22 and 2023-06-08. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
64
Reports
6%
Marked serious
0
With a death outcome
14
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Neurological2733%
Gastrointestinal1417%
Cardiac / Cardiovascular911%
Musculoskeletal911%
General / Systemic (non-local)911%
Injection-site / Local reaction56%
Respiratory34%
Allergic / Anaphylactic22%
Psychiatric / Neuropsychiatric22%
Autoimmune / Immune-mediated11%

Where reports came from

U.S. state of the reporter, where given (top 12).

New Jersey15
Texas9
California5
New York5
North Carolina4
Ohio3
Maryland2
Virginia2
Arizona2
Illinois2
Kentucky2
Pennsylvania2

Reports by month received

2017-031
2017-053
2017-0612
2017-074
2017-0813
2017-094
2017-101
2017-1119
2018-021
2018-032
2018-041
2018-101
2019-081
2023-061

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.